EP3583120
HANNAÐ TRANSFERRÍN VIÐTAKA BINDIFJÖLPEPTÍÐ
:
EP einkaleyfi í gildi á Íslandi:
15.2.2018:
5.10.2022:
18708025.4
:
15.12.2022:
15.1.2023
:
14.2.2038:
14.2.2026:
28.2.2026
:
ENGINEERED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
15.2.2018
5.10.2022
15.12.2022
15.1.2023
14.2.2026
:
Denali Therapeutics Inc.:
161 Oyster Point Boulevard, South San Francisco, California 94080, US
:
CHEN, Xiaocheng:
South San Francisco California 94080, US
:
DENNIS, Mark S.:
South San Francisco California 94080, US
:
KARIOLIS, Mihalis:
South San Francisco California 94080, US
:
SILVERMAN, Adam P.:
South San Francisco California 94080, US
:
SRIVASTAVA, Ankita:
South San Francisco California 94080, US
:
WATTS, Ryan J.:
South San Francisco California 94080, US
:
WELLS, Robert C.:
South San Francisco California 94080, US
:
ZUCHERO, Joy Yu:
South San Francisco California 94080, US
:
Budde Schou A/S:
Dronningens Tværgade 30, DK
:
201762460692 P:
17.2.2017:
US
:
201762543658 P:
10.8.2017:
US
:
201762583314 P:
8.11.2017:
US
:
US2018018371:
15.2.2018
:
C07K 14/79, C07K 14/705, A61K 38/00, A61K 39/00
: 6
: 5.1.2023
: 14.2.2024
: Árnason Faktor ehf.
: 6
: 5.1.2023
: 14.2.2024
: Árnason Faktor ehf.
: 7
: 9.1.2024
: 14.2.2025
: Árnason Faktor ehf.
: 8
: 16.1.2025
: 14.2.2026
: Árnason Faktor ehf.